Palbociclib Combinations in HR+/HER2- Metastatic Breast Cancer Patients: A Non-Interventional Prospective Study on the Treatment Patterns & Clinical Outcomes in Africa Middle East (PRECIOUS)
عنوان الدراسة
Palbociclib Combinations in HR+/HER2- Metastatic Breast Cancer Patients: A Non-Interventional Prospective Study on the Treatment Patterns & Clinical Outcomes in Africa Middle East (PRECIOUS)
داعم الدراسة
pfizer
دواء الدراسة
PALBOCICLIB
رقم بروتوكول الدراسة
A5481150
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Specialist Hospital (Dammam) , King Abdulaziz Medical City NG (Riyadh) , King Khalid University Hospital (Riyadh)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.